2m 2m 2m 2m 2m 2m 2m
Telix Sp ADS (TLX)
NASDAQ
$10.17+$0.17 (+1.66%)
Price as of Jun 23, 2026 4:50 PM EDT- $3.4BMarket Cap
- -38.99%1-Year Change
- BiotechnologyIndustry
Telix Sp ADS (TLX)
$10.17+$0.17 (+1.66%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 803.8M +2.63% | 783.2M N/A | |
Cost of Revenue | 377.4M +37.96% | 273.5M N/A | |
Gross Profit | 426.4M -16.33% | 509.7M N/A | |
Sales and Marketing Expense | 96.8M +13.21% | 85.5M N/A | |
Research and Development Expense | -171.2M -12.02% | -194.6M N/A | |
Depreciation and Amortization Expense | 21.4M +167.01% | 8.0M N/A | |
Total Operating Expenses | 95.8M -26.22% | 129.8M N/A | |
Operating Profit | 29.8M -63.75% | 82.1M N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | -181,000 +120.73% | -82,000 N/A | |
Interest Income and Expense and Net | -181,000 +120.73% | -82,000 N/A | |
Total Nonoperating Income and Expense | 181,000 +120.73% | 82,000 N/A | |
Income before Taxes | -7.1M -114.27% | 49.9M N/A | |
Income Taxes | 1.9M -69.71% | 6.1M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | -7.1M -114.27% | 49.9M N/A | |
Net Income from Continuing Operations Applicable to Common | -7.1M -114.27% | 49.9M N/A | |
Basic EPS and Net Income | -0.02 -100.14% | 15.07 N/A | |
Diluted EPS and Net Income | -0.02 -100.15% | 14.46 N/A | |
Basic Weighted Average Shares | 337.9M +2.01% | 331.2M N/A | |
Diluted Weighted Average Shares | 337.9M +2.01% | 331.2M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 141.9M -80.03% | 710.3M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 141.9M -80.03% | 710.3M N/A | |
Total Current Assets | 330.3M -64.04% | 918.6M N/A | |
Accumulated Depreciation | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 58.7M +30.51% | 44.9M N/A | |
Total Long-Term Assets | 833.7M +39.45% | 597.9M N/A | |
Total Assets | 1.2B -23.24% | 1.5B N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | |
Total Short-Term Debt | 13.1M -30.96% | 19.0M N/A | |
Total Current Liabilities | 231.6M -30.00% | 330.9M N/A | |
Total Long-Term Debt | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 517.0M -16.25% | 617.3M N/A | |
Total Liabilities | 748.6M -21.05% | 948.2M N/A | |
Retained Earnings | -154.5M -27.43% | -213.0M N/A | |
Total Stockholders Equity | 415.4M -26.90% | 568.2M N/A | |
Total Shares Outstanding | 338.8M +1.21% | 334.7M N/A | |
Cash Flow | |||
Cash from Operating Activities | -17.3M -140.19% | 43.0M N/A | |
Capital Expenditures | N/A N/A | N/A N/A | |
Cash from Investing Activities | -285.9M +111.52% | -135.2M N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | -3.7M -100.58% | 638.9M N/A | |
Financials Ratio | |||
Gross Margin | 53.05% N/A | N/A N/A | |
Operating Margin | 3.70% N/A | N/A N/A | |
Return on Assets | -0.53% N/A | N/A N/A | |
Return on Equity | -1.45% N/A | N/A N/A | |
Revenue Growth | 2.63% N/A | N/A N/A | |
Current Ratio | 1.43 N/A | N/A N/A | |
Cash Ratio | 0.61 N/A | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow